Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Pretomanid triple therapy cuts the length of treatment from 18 months to six months.
Evidence supports new PrEP option for gay men and trans women, but there’s no consensus for other groups.
The Food and Drug Administration has approved a new treatment for people living with HIV.
Previously, tests were approved only for use with genital or urine samples.
The spray requires no medical training.
Descovy and Truvada were both highly effective and generally safe options for HIV prevention in a recent clinical trial.
Check out this timeline of the HIV/AIDS in the United States from 1981 to the present.
The Conference on Retroviruses and Opportunistic Infections in Seattle saw many important studies that are advancing the fight against HIV.
Other countries already embrace this form of HIV prevention, also known as “on-demand,” “sex-driven” and “intermittent” PrEP.
An OK would add an indication for the use of these HIV medications among those switching from stable regimens.
Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) includes Pifeltro (doravirine) in a three-drug single-tablet regimen.
Four out of 10 FDA workers are sidelined.
The tablet from the South Korean company Celltrion contains tenofovir disoproxil fumarate and lamivudine.
Gilead Sciences has released multiple combo tablets that contain the updated tenofovir, which is linked to improved bone and kidney makers.
The 1988 “Seize Control of the FDA” AIDS protest forced major change and announced the arrival of ACT UP. Original activists discuss it.
Human papillomavirus vaccine can prevent cervical, anal and oral cancers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.